This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Celgene Corporation. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Julie Selkirk: Innovator in Neurodegenerative Disease Treatment
Introduction
Julie Selkirk is a prominent inventor based in Summit, NJ (US). She has made significant contributions to the field of neurodegenerative diseases through her innovative research and development of novel compounds.
Latest Patents
Julie holds a patent for "Carboxylic acid containing indanyl compounds for the treatment of neurodegenerative diseases." This patent includes compounds and compositions designed to modulate S1P5, which are aimed at treating various neurological diseases. She has 1 patent to her name, showcasing her commitment to advancing medical science.
Career Highlights
Julie is currently employed at Celgene Corporation, where she continues to work on groundbreaking research. Her role at the company allows her to collaborate with other talented professionals in the field.
Collaborations
Some of her notable coworkers include Jeffrey M. Schkeryantz and Philip Stewart Turnbull. Their combined expertise contributes to the innovative environment at Celgene Corporation.
Conclusion
Julie Selkirk is a dedicated inventor whose work in neurodegenerative disease treatment is paving the way for future advancements in medicine. Her contributions are vital to the ongoing fight against neurological disorders.